Is PPAR𝛾 a Prospective Player in HIV-1-Associated Bone Disease?
Currently infection with the human immunodeficiency virus-1 (HIV-1) is in most instances a chronic disease that can be controlled by effective antiretroviral therapy (ART). However, chronic use of ART has been associated with a number of toxicities; including significant reductions in bone mineral d...
Saved in:
Main Authors: | Eoin J. Cotter, Patrick W. Mallon, Peter P. Doran |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2009/421376 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01) -
PPAR𝛾, PTEN, and the Fight against Cancer
by: Rosemary E. Teresi, et al.
Published: (2008-01-01) -
Correlations among PPAR𝜸, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer
by: Valerio Pazienza, et al.
Published: (2012-01-01) -
Combination Therapy of PPAR𝛾 Ligands and Inhibitors of Arachidonic Acid in Lung Cancer
by: Jordi Tauler, et al.
Published: (2008-01-01) -
PPAR𝜸 and Oxidative Stress: Con(𝜷) Catenating NRF2 and FOXO
by: Simone Polvani, et al.
Published: (2012-01-01)